SEC Form D · filed October 11, 2023
Sea Pharmaceuticals, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Walter K. Brown · CAMBRIDGE, MADirectorMichael F. Higgins · CAMBRIDGE, MADirectorShaker J. Sadasivam · CAMBRIDGE, MADirectorNabil J. Elkouh · CAMBRIDGE, MADirectorJames P. Pearson · CAMBRIDGE, MAExec · DirectorMark G. Currie · CAMBRIDGE, MADirectorEric R. Olson · CAMBRIDGE, MADirectorBenjamin F. Cravatt · CAMBRIDGE, MADirectorEric R. Olson · CAMBRIDGE, MADirectorNabil J. Elkouh · CAMBRIDGE, MADirectorWalter K. Brown · CAMBRIDGE, MADirectorMichael F. Higgins · CAMBRIDGE, MADirectorJames P. Pearson · CAMBRIDGE, MAExec · DirectorShaker J. Sadasivam · CAMBRIDGE, MADirectorMark G. Currie · CAMBRIDGE, MADirectorAlbert Siu · Englewood Cliffs, NJDirectorMariel Reilly · Englewood Cliffs, NJDirectorHenry Van Dyke · Englewood Cliffs, NJDirectorJeffrey Schwartz · BOSTON, MADirectorMazen Darwazah · San Diego, CADirectorSuzane San · San Diego, CAExec · DirectorMinami Maeda · San Diego, CADirectorBenjamin F. Cravatt · CAMBRIDGE, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗